Is herpes zoster always unilateral?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Herpes Zoster Always Unilateral?

Herpes zoster typically presents as a unilateral, dermatomal rash, but it is not always strictly unilateral—disseminated herpes zoster can involve multiple dermatomes bilaterally, particularly in immunocompromised patients. 1

Classic Presentation: Unilateral Dermatomal Distribution

The hallmark presentation of herpes zoster is indeed unilateral:

  • The vesicular rash characteristically appears in a unilateral and dermatomal pattern along dorsal root or cranial nerve ganglia. 2, 3, 4
  • This unilateral distribution reflects the pathophysiology: VZV reactivates from a single dorsal root ganglion or cranial nerve ganglion where it has remained latent since primary varicella infection. 5, 6
  • The rash progresses through stages of clear vesicular clusters, pustulation, ulceration, and crusting, all confined to the affected dermatome(s) on one side of the body. 2

Important Exception: Disseminated Herpes Zoster

Disseminated herpes zoster is defined by skin lesions involving more than three dermatomes, which can cross the midline and appear bilateral. 1

High-Risk Populations for Dissemination

  • Immunocompromised patients—including those on active chemotherapy, with HIV infection, receiving chronic immunosuppressive agents, or post-organ transplantation—are at substantially higher risk for disseminated disease. 1
  • Patients on B-cell depleting therapies (e.g., ocrelizumab, rituximab, ofatumumab) face the highest risk of severe and disseminated herpes zoster. 1

Clinical Implications of Dissemination

  • Disseminated disease may also involve visceral organs (hepatitis, pneumonia, encephalitis) or present with hemorrhagic lesions, requiring escalation to intravenous acyclovir 10 mg/kg every 8 hours. 1
  • Immunocompromised patients may develop chronic poorly healing ulcers with persistent viral replication, further complicating the clinical picture. 7

Common Pitfalls to Avoid

  • Do not assume bilateral or multi-dermatomal lesions exclude herpes zoster—this presentation mandates urgent evaluation for disseminated disease and potential visceral involvement. 1
  • In immunocompromised hosts, loss of the typical vesicular component can occur, with lesions appearing as chronic ulcers from onset, making diagnosis more challenging. 7
  • Clinicians may underestimate the severity when atypical presentations lack characteristic vesicular appearance, delaying appropriate intravenous therapy. 7

Transmission Considerations

  • Patients with disseminated zoster require both airborne and contact precautions in healthcare settings, not just contact precautions as with localized disease. 1
  • All patients with active herpes zoster should avoid contact with susceptible individuals until all lesions have crusted, as the virus can be transmitted through direct contact or aerosolized vesicular fluid. 5, 1

References

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Shingrix for Herpes Zoster: A Review.

Skin therapy letter, 2019

Research

Herpes zoster: A clinicocytopathological insight.

Journal of oral and maxillofacial pathology : JOMFP, 2016

Research

[Herpes Zoster Vaccine].

Uirusu, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Herpes zoster (shingles) and postherpetic neuralgia.

Mayo Clinic proceedings, 2009

Guideline

Pathophysiology and Clinical Implications of Herpes Zoster Cicatricial Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.